These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 19951251)
1. Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme. Gutova M; Najbauer J; Chen MY; Potter PM; Kim SU; Aboody KS Curr Stem Cell Res Ther; 2010 Sep; 5(3):273-6. PubMed ID: 19951251 [TBL] [Abstract][Full Text] [Related]
2. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Danks MK; Yoon KJ; Bush RA; Remack JS; Wierdl M; Tsurkan L; Kim SU; Garcia E; Metz MZ; Najbauer J; Potter PM; Aboody KS Cancer Res; 2007 Jan; 67(1):22-5. PubMed ID: 17210679 [TBL] [Abstract][Full Text] [Related]
3. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use. Metz MZ; Gutova M; Lacey SF; Abramyants Y; Vo T; Gilchrist M; Tirughana R; Ghoda LY; Barish ME; Brown CE; Najbauer J; Potter PM; Portnow J; Synold TW; Aboody KS Stem Cells Transl Med; 2013 Dec; 2(12):983-92. PubMed ID: 24167321 [TBL] [Abstract][Full Text] [Related]
4. Human neural stem cell tropism to metastatic breast cancer. Zhao D; Najbauer J; Annala AJ; Garcia E; Metz MZ; Gutova M; Polewski MD; Gilchrist M; Glackin CA; Kim SU; Aboody KS Stem Cells; 2012 Feb; 30(2):314-25. PubMed ID: 22084033 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesterase. Lim SH; Choi SA; Lee JY; Wang KC; Phi JH; Lee DH; Song SH; Song JH; Jin X; Kim H; Lee HJ; Lim I; Kim SU; Kim SK Cancer Gene Ther; 2011 Nov; 18(11):817-24. PubMed ID: 21869821 [TBL] [Abstract][Full Text] [Related]
6. Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma. Gutova M; Shackleford GM; Khankaldyyan V; Herrmann KA; Shi XH; Mittelholtz K; Abramyants Y; Blanchard MS; Kim SU; Annala AJ; Najbauer J; Synold TW; D'Apuzzo M; Barish ME; Moats RA; Aboody KS Gene Ther; 2013 Feb; 20(2):143-50. PubMed ID: 22402322 [TBL] [Abstract][Full Text] [Related]
7. Effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta or carboxyl esterase on the growth of LNCaP rrostate cancer cells. Yi BR; Hwang KA; Kim YB; Kim SU; Choi KC Int J Mol Sci; 2012 Sep; 13(10):12519-32. PubMed ID: 23202910 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-targeted over-expression of carboxylesterase as a means of increasing tumour sensitivity to irinotecan (CPT-11). Matzow T; Cowen RL; Williams KJ; Telfer BA; Flint PJ; Southgate TD; Saunders MP J Gene Med; 2007 Apr; 9(4):244-52. PubMed ID: 17397102 [TBL] [Abstract][Full Text] [Related]
9. An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11. Wierdl M; Tsurkan L; Hyatt JL; Edwards CC; Hatfield MJ; Morton CL; Houghton PJ; Danks MK; Redinbo MR; Potter PM Cancer Gene Ther; 2008 Mar; 15(3):183-92. PubMed ID: 18188187 [TBL] [Abstract][Full Text] [Related]
10. Co-treatment with therapeutic neural stem cells expressing carboxyl esterase and CPT-11 inhibit growth of primary and metastatic lung cancers in mice. Yi BR; Kim SU; Choi KC Oncotarget; 2014 Dec; 5(24):12835-48. PubMed ID: 25544747 [TBL] [Abstract][Full Text] [Related]
11. Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy. Danks MK; Morton CL; Krull EJ; Cheshire PJ; Richmond LB; Naeve CW; Pawlik CA; Houghton PJ; Potter PM Clin Cancer Res; 1999 Apr; 5(4):917-24. PubMed ID: 10213229 [TBL] [Abstract][Full Text] [Related]
12. Genetically-engineered human neural stem cells with rabbit carboxyl esterase can target CNS lymphoma. Kang W; Jin J; Yang H; Seol HJ; Kim KH; Lee JI; Kim SU; Joo KM; Nam DH Anticancer Res; 2013 Dec; 33(12):5335-42. PubMed ID: 24324067 [TBL] [Abstract][Full Text] [Related]
13. Gene-directed enzyme prodrug therapy for osteosarcoma: sensitization to CPT-11 in vitro and in vivo by adenoviral delivery of a gene encoding secreted carboxylesterase-2. Oosterhoff D; Witlox MA; van Beusechem VW; Haisma HJ; Schaap GR; Bras J; Kruyt FA; Molenaar B; Boven E; Wuisman PI; Pinedo HM; Gerritsen WR Mol Cancer Ther; 2003 Aug; 2(8):765-71. PubMed ID: 12939466 [TBL] [Abstract][Full Text] [Related]
14. A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma. Seo GM; Rachakatla RS; Balivada S; Pyle M; Shrestha TB; Basel MT; Myers C; Wang H; Tamura M; Bossmann SH; Troyer DL Mol Biol Rep; 2012 Jan; 39(1):157-65. PubMed ID: 21567204 [TBL] [Abstract][Full Text] [Related]
15. In vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local treatment of solid tumors. Kojima A; Hackett NR; Ohwada A; Crystal RG J Clin Invest; 1998 Apr; 101(8):1789-96. PubMed ID: 9541511 [TBL] [Abstract][Full Text] [Related]
16. Tumor-specific gene therapy for pancreatic cancer using human neural stem cells encoding carboxylesterase. Choi SS; Yoon K; Choi SA; Yoon SB; Kim SU; Lee HJ Oncotarget; 2016 Nov; 7(46):75319-75327. PubMed ID: 27659534 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma. Yano H; Kayukawa S; Iida S; Nakagawa C; Oguri T; Sanda T; Ding J; Mori F; Ito A; Ri M; Inagaki A; Kusumoto S; Ishida T; Komatsu H; Inagaki H; Suzuki A; Ueda R Cancer Sci; 2008 Nov; 99(11):2309-14. PubMed ID: 18771527 [TBL] [Abstract][Full Text] [Related]
18. Anti-Cancer Effect of Neural Stem Cells Transfected with Carboxylesterase and sTRAIL Genes in Animals with Brain Lesions of Lung Cancer. Kim JH; Ahn JS; Lee DS; Hong SH; Lee HJ Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631070 [TBL] [Abstract][Full Text] [Related]
20. A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38. Stubdal H; Perin N; Lemmon M; Holman P; Bauzon M; Potter PM; Danks MK; Fattaey A; Dubensky T; Johnson L Cancer Res; 2003 Oct; 63(20):6900-8. PubMed ID: 14583489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]